PCI "economically dominant" over CABG in high-risk patients

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1566, 2006-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

R-CHOP economically dominant over CHOP in DLBCL

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 544, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

R-CHOP economically dominant over CHOP in DLBCL

By  

Inpharma, Vol. 1, Iss. 1619, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Renal Transplantation in High-Risk Patients

By Weimert Nicole A.  

Drugs, Vol. 67, Iss. 11, 2007-01 ,pp. : 1603-1627

Adis International

Access to resources Recommend Favorite

Myocardial Revascularization Strategies in Diabetic Patients with Multi-Vessel Disease: CABG vs DES-Based PCI

By  

Current Pharmaceutical Design, Vol. 20, Iss. 28, 2014-08 ,pp. : 4589-4596

Bentham Science Publishers

Access to resources Recommend Favorite

High-dose eptifibatide cost saving in low-risk PCI patients?

By  

Inpharma, Vol. 1, Iss. 1285, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite